Dragon retains leading investor relations firm

VANCOUVER, March 17  /PRNewswire-FirstCall/ -- Dragon Pharmaceutical Inc. ("Dragon" or the "Company" TSX: DDD; OTCBB: DRUG; BBSE: DRP), a leading international pharmaceutical company, today announced it has retained cQuest, a capital markets advisory affiliate of Christensen, to facilitate and execute its investor and media relations campaigns. cQuest specializes in assisting companies with market capitalizations of less than $200 million to achieve fair market valuation and strengthen brand recognition in the global financial markets and financial media. Retaining cQuest reinforces Dragon's commitment to maximizing shareholder value by improving external communications and increasing visibility within the financial community.

"We are very excited to be working with cQuest," said Ms. Maggie Deng, Dragon's Chief Operating Officer. "The Dragon management team is committed to creating value for our shareholders with best-in-class communications and has placed a great deal of effort in finding the right investor relations firm to accomplish this goal. With its extensive global investor relations expertise with small and micro-cap companies and depth of pharmaceutical industry experience, we are confident that cQuest will assist in positioning Dragon Pharmaceutical within the investor community with a more comprehensive and customized investor and media relations program, a critical step to achieving our long term goals."

  About Dragon Pharmaceutical Inc.
  --------------------------------


Dragon Pharmaceutical, headquartered in Vancouver, Canada, is a leading manufacturer and distributor of a broad line of high-quality antibiotic products including 7-ACA, a key intermediate to produce cephalosporin antibiotics, Clavulanic Acid, and formulated cephalosporin antibiotic drugs. Dragon is the third largest 7-ACA producer and the first manufacturer and market leader of Clavulanic Acid products in China. Dragon utilizes its nationwide sales distribution network, close customer relationships, understanding of local markets and customer needs and low cost structure to outperform its international and domestic peers. With an annual capacity of 780 tons, Dragon is the largest exporter of 7-ACA in China. To learn more about Dragon Pharmaceutical Inc., please visit http://www.dragonpharma.com/.

  About cQuest
  ------------


cQuest is an affiliate of Christensen, a leading global capital markets advisory firm with offices in New York, Hong Kong, Phoenix, Montreal and Calgary. Providing its clients with a customized choice of investor relations and financial communication solutions, designed to fit clients' individual needs, cQuest assists companies with market capitalizations of less than $200 million achieve fair market valuation and strengthened brand recognition in the global financial markets.

More information can be found at http://www.christensenir.com/.

This press release contains forward looking statements, including but not limited to, that the Company will continue to experience growth in sales of its main products, that it will continue to be able to improve its production technology and efficiency, that it will continue to achieve continuous growth in business and profitability in the near future. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward looking statements. Readers should not place undue reliance on forward looking statements, which only reflect the views of management as of the date hereof. The Company does not undertake the obligation to publicly revise these forward looking statements to reflect subsequent events or circumstances. Readers should carefully review the risk factors and other factors described in its periodic reports filed with the Securities and Exchange Commission.

CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, Chief Operating Officer, Telephone: [phone] or North America Toll Free: 1-877-388-3784, Email: , Website: http://www.dragonpharma.com/ 

DATASOURCE: Dragon Pharmaceutical Inc.



CONTACT: Dragon Pharmaceutical Inc., Maggie Deng, Chief Operating

Officer, Telephone: [phone] or North America Toll Free: 1-877-388-3784,

Email: , Website: http://www.dragonpharma.com/

Copyright